Theophylline sustained release tablet

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4837032
SERIAL NO

06825909

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compressed tablets from which theophylline is released at a steady rate with twelve hour dosing intervals are disclosed. The tablets contain 43 to 50 weight percent theophylline; 10 to 20 weight percent water insoluble polymer; 10 to 15 weight percent of a polymer selected from the group consisting of water soluble polymers and hydrophilic gel formers which swell in water; and 5 to 15 weight percent acid insoluble polymer having carboxylic groups. The tablet may additionally contain 5 to 9 weight percent hydrophobic lubricant. A preferred composition contains: 43 to 50 weight percent theophylline; 10 to 20 weight percent polyvinyl acetate; 10 to 15 weight percent polyvinylpyrrolidine; 5 to 15 weight percent cellulose acetate phthalate and optionally contains 5 to 7 weight percent of a lubricant mixture containing stearic acid, magnesium stearate and talc.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FARVALSA A GBAARERSTRASSE 2 6304 ZUG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ortega, Aracelis M Caracas, VE 2 44

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation